< Return to PAMED News

Increased Risk of Withdrawal Symptoms Associated with 7-hydroxymitragynine (7-OH) and Tianeptine After Federal Scheduling

Last Updated

Aug 19, 2026, 15:42 PM

pamed-member-resource

Leave a comment
Newest on top Oldest on top
Load more comments
Login to be able to comment